Industry-chain Research Brief

Hunan Warrant Pharmaceutical Co., Ltd.: Biomedicine and medical devices Little Giant Industry Chain Brief

Hunan · Biomedicine and medical devices · 2026-06-14

English company profile Full Chinese report All report summaries

English Summary

Hunan Warrant Pharmaceutical Co., Ltd. is a China Little Giant company report summary for overseas readers. The company is associated with Hunan. The report is indexed under Biomedicine and medical devices. The Chinese report was published on 2026-06-14. The summary covers company profile, product direction, industry-chain role, technology, patent/R&D signals, scale indicators and policy-material checkpoints.

Report Snapshot

CompanyHunan Warrant Pharmaceutical Co., Ltd.
RegionHunan
IndustryBiomedicine and medical devices
Published2026-06-14
Chinese reportOpen
CompanyHunan Warrant Pharmaceutical Co., Ltd.
Region / IndustryHunan · Biomedicine and medical devices
Recognition2019 1st batch
Patent signal67 patent-related records

Company and Recognition Snapshot

Hunan Warrant Pharmaceutical Co., Ltd. is indexed as a national-level Little Giant enterprise in Hunan. The English profile places the company under Biomedicine and medical devices and records 2019 1st batch as the available recognition context.

Recognition batch2019 1st batch
RegionHunan
IndustryBiomedicine and medical devices
Registered capitalRMB 131.32 million
Employee signal364 employees
Listed statusNot listed
Patent signal67 patent-related records
R&D signalR&D investment detail not published in the English dataset

Business and Industry-chain Position

Chinese public records indicate software, systems and digital-technology activity, medical-device or biomedicine activity, R&D, design and engineering activity. The recorded industry-chain position is Biomedicine and medical devices / Recorded position. This places the company in a policy-relevant segment for peer comparison by region, industry and batch.

Technology, Patent and R&D Signals

The public profile records 67 patent-related records. The R&D signal is: R&D investment detail not published in the English dataset. Patent and R&D information should be read with product direction, customer evidence and chain position rather than as isolated threshold items.

Policy-material Review Points

  • Verify whether the company's main business, niche market and product evidence all point to Biomedicine and medical devices.
  • Check that patent, R&D, employee and financial fields support the same core product direction.
  • Compare the company with peers in the same province, industry and recognition batch before using the profile for supplier screening or policy research.
  • Use the linked Chinese source report for original-language evidence and source links.

Original Report and Profile

For the underlying database record, open the English company profile. For full-length analysis, original-language wording and public evidence links, open the Chinese source report.

Related Search Paths